SOURCE: PURE Bioscience, Inc

PURE Bioscience, Inc

October 17, 2014 08:32 ET

PURE Hard Surface Disinfectant Now Available for Use in Subway® Restaurants Nationwide

New Generation of Effective, Eco-Friendly Pathogen Control

SAN DIEGO, CA--(Marketwired - Oct 17, 2014) - PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that PURE Hard Surface disinfectant has been made available for use in the almost 27,000 SUBWAY® franchised locations in the U.S.

PURE Hard Surface disinfectant, which is powered by the patented, non-toxic, environmentally friendly SDC antimicrobial molecule, fits perfectly into SUBWAY®'s commitment to greener living and its food safety protocol. A leader in the quick service restaurant industry, all SUBWAY® restaurants are required to follow policies in support of SUBWAY®'s overall commitment to make its restaurants and operations as environmentally and socially responsible as possible. The availability of the powerful PURE Hard Surface disinfectant will strengthen the quick service restaurant chain's sanitization program.

"Food safety and food quality are our top priorities and our goal is to serve food that consistently meets the highest quality and safety standards," said Eric Wolfe, Manager of Global Product Quality for the SUBWAY® brand. "We think PURE Hard Surface disinfectant is a powerful, yet safe and environmentally friendly way to help franchisees meet those standards."

Hank R. Lambert, CEO of PURE, added that, "We see our product as an ideal fit with SUBWAY®'s strategy to find new and innovative ways to improve operations and use even more effective natural, green products. We will make PURE Hard Surface disinfectant available to franchisees so they can immediately begin to use the product for an enhanced level of food safety protection." 

About SUBWAY® Restaurants
Since 1965, SUBWAY® owners have been devoted to offering customers customized made to order sandwiches with a wide range of better-for-you options. Providing easy access to vegetables, detailed nutrition, dietary, and healthy lifestyle information has been a priority for the SUBWAY® chain for many years, earning the American Heart Association's Heart Check Meal Certification in 2012 for many Fresh Fit™ meal options. As the world's largest restaurant chain, thousands of dedicated entrepreneurs have the opportunity to run their own business, while playing an important role in their communities. To learn more information about us, visit http://www.subway.com, like us on Facebook https://www.facebook.com/subway and follow us on https://twitter.com/subway.
SUBWAY® is a registered trademark of Doctor's Associates Inc. 

Franchise Brands, LLC, an affiliate of Doctor's Associates Inc. (the franchisor of SUBWAY® restaurants), as previously disclosed under Form 13G, holds approximately an 18% equity interest in PURE Bioscience, Inc.

About PURE Bioscience, Inc.
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the Company's cash position and liquidity requirement; the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including acceptance of the Company's Hard Surface Disinfectant by SUBWAY franchisees; the ability of the Company to develop effective new products and receive regulatory approvals of such products; competitive factors; dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission; including our quarterly report on Form 10-Q filed on June 10, 2014. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Contact Information

  • SUBWAY(R) Contacts:
    SUBWAY(R) Public Relations
    203-877-4281
    Kevin Kane ext. 1329

    PURE Contacts:
    Tom Hemingway
    Redwood Investment Group
    714-978-4425
    Email Contact

    Terri MacInnis
    VP of IR
    Bibicoff + MacInnis, Inc.
    818-379-8500
    Email Contact

    Peter C. Wulff
    CFO & COO
    PURE Bioscience, Inc.
    619-596-8600 ext.111
    Email Contact